Name: Beinaglutide Injection (Fisulimei) 4.2mg – Pre-Filled Pen for Laboratory Research Use Only - Arizona-mall
Price: 1.00 HKD
Availability: InStock

Beinaglutide Injection (Fisulimei) 4.2mg – Pre-Filled Pen for Laboratory Research Use Only

$1.00

Beinaglutide Injection (Fisulimei) delivers 4.2mg (42,000U) per 2.1ml pre-filled pen. Manufactured by Shanghai Rennai Biopharmaceutical Co., Ltd. For laboratory research only. Wholesale and retail orders accepted.?For wholesale prices, other specifications and uses, please consult our staff?

Compare

描述

Beinaglutide is a GLP-1 receptor agonist that mimics endogenous glucagon-like peptide-1 to regulate glucose metabolism, insulin secretion, and appetite. It has been widely studied in obesity, metabolic syndrome, and type 2 diabetes models.

This product comes in a pre-filled injection pen containing 2.1ml of solution (4.2mg, 42,000U). Manufactured by Shanghai Rennai Biopharmaceutical Co., Ltd., it is NMPA-approved under S20230042 and intended only for laboratory use.

?? Strictly for research use only. Not for human or veterinary use.

Contents hide

1 Product Specifications

2 Mechanism of Action & Research Applications

3 Safety & Handling

4 Research Use Disclaimer

Product Specifications

Parameter	Details
Product Name	Beinaglutide Injection (Fisulimei)
Generic Name	Beinaglutide
CAS Number	666824-32-6
Molecular Formula	C174H265N51O52S
Molecular Weight	~3900 Da (approximate peptide MW)
Dosage Form	Lyophilized powder in pre-filled injection pen
Strength	4.2mg (42,000 Units) per 2.1ml
Quantity	1 pre-filled pen per box
Approval Number	S20230042 (China NMPA)
Product Code	86980532000368
Manufacturer	Shanghai Rennai Biopharmaceutical Co., Ltd.
Barcode	6970720720028
Intended Use	Laboratory research only
Storage Conditions	Store refrigerated at 2–8°C, protected from light

Mechanism of Action & Research Applications

Beinaglutide is a recombinant human GLP-1 analog that binds to GLP-1 receptors, stimulating glucose-dependent insulin secretion, suppressing glucagon, and slowing gastric emptying. In research, it is employed to investigate:

Glucose metabolism and insulin regulation
Weight loss and appetite modulation pathways
Type 2 diabetes mechanisms
Gut-brain axis signaling
GLP-1 receptor pharmacodynamics

Safety & Handling

Use Restriction: For laboratory research use only. Not for clinical, diagnostic, or veterinary purposes.
Handling: Use gloves and protective lab equipment. Avoid direct contact.
Storage: Keep refrigerated at 2–8°C. Do not freeze. Avoid exposure to light.
Disposal: Dispose of according to institutional biosafety guidelines.

Research Use Disclaimer

This product is intended exclusively for laboratory research purposes. It is not approved for use in humans or animals. Any misuse may result in health or legal risks. Handle in compliance with institutional biosafety protocols.

其他信息

重量	1 公斤
尺寸	26 × 23 × 26 厘米

评价

目前还没有评价

成为第一个“Beinaglutide Injection (Fisulimei) 4.2mg – Pre-Filled Pen for Laboratory Research Use Only” 的评价者

Q1: Is this product for human use?

A1: No. Beinaglutide Injection is strictly for laboratory research and not approved for clinical or therapeutic use.

Q2: Can I purchase Beinaglutide in bulk?

A2: Yes. We offer both retail and wholesale options. Contact us for quotes and MOQ.

Q3: What documentation is available?

A3: COA (Certificate of Analysis) and SDS (Safety Data Sheet) are available upon request.

Q4: What are common research applications of Beinaglutide?

A4: It is commonly used in metabolic disease models, including type 2 diabetes, obesity, and GLP-1 receptor-related pharmacology.

Q5: Is Beinaglutide the same as benaglutide?

A5: Yes. Beinaglutide and Benaglutide are variant spellings of the same compound—a GLP-1 receptor agonist used in experimental settings.